- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Nausea and vomiting
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1.2MB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 660KB)
Fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) – March 2023
Fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride): Solution concentrate for I.V. infusion containing fosnetupitant 235 mg and palonosetron 0.25 mg in 20 mL vial; Akynzeo®IV
Last updated
30 June 2023